Michael A. Galella

915 total citations
21 papers, 237 citations indexed

About

Michael A. Galella is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Michael A. Galella has authored 21 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Michael A. Galella's work include Chemical Synthesis and Analysis (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Apelin-related biomedical research (3 papers). Michael A. Galella is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Apelin-related biomedical research (3 papers). Michael A. Galella collaborates with scholars based in United States, Sweden and Germany. Michael A. Galella's co-authors include Sean P. Delaney, Duohai Pan, Timothy M. Korter, Shawn X. Yin, Zili Xiao, Mary F. Malley, Jack Z. Gougoutas, Sarah C. Traeger, David S. Weinstein and Ruth R. Wexler and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Michael A. Galella

20 papers receiving 233 citations

Peers

Michael A. Galella
Michael B. Tollefson United States
Milana Maletic United States
Jonas Y. Buser United States
Anil Yadav South Korea
Matthew Cox Australia
Michael A. Galella
Citations per year, relative to Michael A. Galella Michael A. Galella (= 1×) peers Terukage Hirata

Countries citing papers authored by Michael A. Galella

Since Specialization
Citations

This map shows the geographic impact of Michael A. Galella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Galella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Galella more than expected).

Fields of papers citing papers by Michael A. Galella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Galella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Galella. The network helps show where Michael A. Galella may publish in the future.

Co-authorship network of co-authors of Michael A. Galella

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Galella. A scholar is included among the top collaborators of Michael A. Galella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Galella. Michael A. Galella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wurtz, Nicholas R., James A. Johnson, Andrew Q. Viet, et al.. (2022). Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists. ACS Medicinal Chemistry Letters. 13(6). 943–948. 4 indexed citations
2.
Ji, Jiang, Jeffrey S. Bostwick, Peter S. Gargalovic, et al.. (2021). Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists. Bioorganic & Medicinal Chemistry Letters. 50. 128325–128325. 6 indexed citations
3.
Johnson, James A., Soong‐Hoon Kim, Jiang Ji, et al.. (2021). Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. Journal of Medicinal Chemistry. 64(6). 3086–3099. 14 indexed citations
4.
Cruz, Thomas E. La, Francisco González‐Bobes, Martin D. Eastgate, et al.. (2021). Scalable Asymmetric Synthesis of the All Cis Triamino Cyclohexane Core of BMS-813160. The Journal of Organic Chemistry. 87(4). 1996–2011. 3 indexed citations
5.
Jiang, Bin, James J.‐W. Duan, Arun Kumar Gupta, et al.. (2020). Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists. Bioorganic & Medicinal Chemistry Letters. 30(17). 127392–127392. 9 indexed citations
6.
Marcoux, David, Myra Beaudoin Bertrand, Carolyn A. Weigelt, et al.. (2020). Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists. Bioorganic & Medicinal Chemistry Letters. 30(19). 127466–127466. 4 indexed citations
7.
Shi, Qing, Nathaniel S. Greenwood, Hyunsoo Park, et al.. (2019). One-Step Diastereoselective Pyrrolidine Synthesis Using a Sulfinamide Annulating Reagent. Organic Letters. 21(22). 9198–9202. 14 indexed citations
8.
Su, Shun, Ying Han, Jeffrey S. Bostwick, et al.. (2019). Biphenyl Acid Derivatives as APJ Receptor Agonists. Journal of Medicinal Chemistry. 62(22). 10456–10465. 15 indexed citations
9.
Wang, Tammy C., Jennifer X. Qiao, David S. Taylor, et al.. (2018). Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3721–3725. 7 indexed citations
10.
Shi, Qing, Michael A. Galella, Hyunsoo Park, et al.. (2017). Protected Chloroethyl and Chloropropyl Amines as Conformationally Unrestricted Annulating Reagents. Organic Letters. 20(2). 337–340. 8 indexed citations
11.
Galella, Michael A.. (2017). To solvate or not to solvate? A crystallographic evaluation of the isostructural solvated and non-solvated crystal forms of an active pharmaceutical ingredient. Acta Crystallographica Section A Foundations and Advances. 73(a1). a330–a330.
12.
Shan, Weifang, Aaron Balog, Xiao Zhu, et al.. (2016). [2.2.1]-Bicyclic sultams as potent androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(23). 5707–5711. 11 indexed citations
13.
Shi, Qing, Douglas G. Batt, Michael A. Galella, et al.. (2015). Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity. Bioorganic & Medicinal Chemistry Letters. 26(2). 662–666. 2 indexed citations
14.
Narang, Ajit S., Sherif I.F. Badawy, Qingmei Ye, et al.. (2015). Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug. Pharmaceutical Research. 32(8). 2579–94. 13 indexed citations
16.
Liu, Chunjian, James C. Lin, Christoph Gesenberg, et al.. (2013). Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(10). 3028–3033. 8 indexed citations
17.
Delaney, Sean P., Duohai Pan, Michael A. Galella, Shawn X. Yin, & Timothy M. Korter. (2012). Understanding the Origins of Conformational Disorder in the Crystalline Polymorphs of Irbesartan. Crystal Growth & Design. 12(10). 5017–5024. 46 indexed citations
18.
Xiao, Zili, Michael G. Yang, Andrew J. Tebben, Michael A. Galella, & David S. Weinstein. (2010). Novel two-step, one-pot synthesis of primary acylureas. Tetrahedron Letters. 51(44). 5843–5844. 13 indexed citations
19.
Salvati, Mark, Aaron Balog, Weifang Shan, et al.. (2008). Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 1910–1915. 20 indexed citations
20.
Shi, Yan, Jing Zhang, Philip D. Stein, et al.. (2003). One-Pot Synthesis and Conformational Features ofN,N-Disubstituted Ketene Aminals. The Journal of Organic Chemistry. 69(1). 188–191. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026